Back to Results
First PageMeta Content
Takeda Pharmaceutical Company / Pharmaceutical industry / Millennium Pharmaceuticals / Sales / Dexlansoprazole / Pharmacology / Pharmaceutical sciences / Chemistry


Financial Results for FY2010 DATA BOOK Takeda Pharmaceutical Company Limited
Add to Reading List

Document Date: 2012-12-10 03:13:42

Open Document

File Size: 1,45 MB

Share Result on Facebook

Company

Takeda Group / TPC group / Takeda Pharma GmbH / Candesartan Worldwide / Pioglitazone Worldwide / Takeda UK Limited / Takeda Italia Farmaceutici S.p.A. / Lansoprazole Worldwide / Millennium Pharmaceuticals Inc. / DATA BOOK Takeda Pharmaceutical Company Limited / Estimate Leuprorelin Worldwide / Takeda Pharmaceuticals North America Inc. / /

Continent

Asia / Europe / Americas / /

Country

Japan / United States / /

Event

Dividend Issuance / /

/

IndustryTerm

individual products / pharmaceutical leadership / /

MedicalCondition

measles /rubella / Insomnia / Hypertension / Colorectal cancer / live attenuated measles / Rheumatoid arthritis / Diabetes / endometriosis / Alzheimer-type dementia / rubella / Osteoporosis / Peptic ulcers / Prostate cancer / breast cancer / /

/

Product

Pioglitazone / Vectibix / Velcade / Enbrel / Rozerem / Lansoprazole / Amitiza / Actos / Major products sales FY07 FY08 FY09 FY2010 vs. FY2009 increase/ decrease FY11 Estimate Alinamin tablet / /

PublishedMedium

Financial News / /

URL

http /

SocialTag